Erik de Blois

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 5

Top Topics

Molecularly Imprinted

Loop Mediated Isothermal Amplification

Quality Control

Top Venues

EJNMMI radiopharmacy and chemistry

Contrast media & molecular imaging

This page only lists publications with an associated author ORCID identifier.

Publications

Eline L Hooijman, Valery Radchenko, Sui Wai Ling, Mark Konijnenberg, Tessa Brabander, Stijn L W Koolen, Erik de Blois
Implementing Ac-225 labelled radiopharmaceuticals: practical considerations and (pre-)clinical perspectives. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Eline L Hooijman, Valery Radchenko, Sui Wai Ling, Mark Konijnenberg, Tessa Brabander, Stijn L W Koolen, Erik de Blois
Implementing Ac-225 labelled radiopharmaceuticals: practical considerations and (pre-)clinical perspectives. EJNMMI radiopharmacy and chemistry 9 (1) (2024)
Eline L Hooijman, Carolline M Ntihabose, Thom G A Reuvers, Julie Nonnekens, Else A Aalbersberg, Jordy R J P van de Merbel, Judith E Huijmans, Stijn L W Koolen, Jeroen J M A Hendrikx, Erik de Blois
Radiolabeling and quality control of therapeutic radiopharmaceuticals: optimization, clinical implementation and comparison of radio-TLC/HPLC analysis, demonstrated by [ 177 Lu]Lu-PSMA. EJNMMI radiopharmacy and chemistry 7 (1) (2022)
Marcus C M Stroet, Erik de Blois, Joost Haeck, Yann Seimbille, Laura Mezzanotte, Marion de Jong, Clemens W G M Löwik, Kranthi M Panth
In Vivo Evaluation of Gallium-68-Labeled IRDye800CW as a Necrosis Avid Contrast Agent in Solid Tumors. Contrast media & molecular imaging 2021 (2021)
Erik de Blois, Rory M S de Zanger, Ho Sze Chan, Mark Konijnenberg, Wouter A P Breeman
Radiochemical and analytical aspects of inter-institutional quality control measurements on radiopharmaceuticals. EJNMMI radiopharmacy and chemistry 4 (1) (2019)